Becton, Dickinson and Company
BDX · NYSE
Bulios Fair Price
$271.96
49.0% upside
Preț actual
$182.55
Potrivit Bulios Fair Price, acțiunile BDX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Becton, Dickinson and Company (BDX) is an American company operating in the field of healthcare technologies and medical devices. The company specializes in the development, manufacturing, and distribution of a wide range of products for diagnostics, therapy, and treatment in various healthcare areas. Its products include items such as needles, syringes, infectious disease diagnostic tests, diabetic products, and other medical devices. Becton, Dickinson and Company is known for its innovative technologies and high-quality products that contribute to improving patient care and enhancing the efficiency of medical procedures. The company operates globally and serves as a partner for healthcare institutions, hospitals, and medical professionals worldwide. Shares of Becton, Dickinson and Company (BDX) may represent an interesting investment opportunity for investors monitoring the healthcare sector and innovations in medical technologies.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas E. Polen Jr.
Employees
72,000
Headquarters
Franklin Lakes
Evenimente viitoare
Earnings
Upcoming earnings report